EDGAR Filing Documents for 0001493152-22-010231

Form 8-K - Current report:

SEC Accession No. 0001493152-22-010231

Filing Date

2022-04-18

Accepted

2022-04-18 16:35:12

Documents

Period of Report

2022-04-18

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	34033
	Complete submission text file	0001493152-22-010231.txt		202924

Data Files

Seq	Description	Document	Type	Size
2	XBRL SCHEMA FILE	eltp-20220418.xsd	EX-101.SCH	3042
3	XBRL LABEL FILE	eltp-20220418_lab.xml	EX-101.LAB	34476
4	XBRL PRESENTATION FILE	eltp-20220418_pre.xml	EX-101.PRE	22601
6	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3394

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)